| On the origin of leprosy M Monot, N Honoré, T Garnier, R Araoz, JY Coppée, C Lacroix, S Sow, ... Science, 2005 | 664 | 2005 |
| Factors contributing to the delay in diagnosis and continued transmission of leprosy in Brazil–an explorative, quantitative, questionnaire based study M Henry, N GalAn, K Teasdale, R Prado, H Amar, MS Rays, L Roberts, ... PLoS neglected tropical diseases 10 (3), e0004542, 2016 | 136 | 2016 |
| Multidrug therapy for leprosy: a game changer on the path to elimination CS Smith, A Aerts, P Saunderson, J Kawuma, E Kita, M Virmond The Lancet Infectious Diseases 17 (9), e293-e297, 2017 | 118 | 2017 |
| Neuropathic pain in leprosy patients P Stump, R Baccarelli, L Marciano, JRP Lauris, MJ Teixeira, S Ura, ... International journal of leprosy and other mycobacterial diseases 72 (2 …, 2004 | 85 | 2004 |
| Toll-like receptor 1 N248S single-nucleotide polymorphism is associated with leprosy risk and regulates immune activation during mycobacterial infection C de Sales Marques, VN Brito-de-Souza, LTA Guerreiro, JH Martins, ... The Journal of infectious diseases 208 (1), 120-129, 2013 | 77 | 2013 |
| Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme JH Richardus, A Tiwari, T Barth-Jaeggi, MA Arif, NL Banstola, R Baskota, ... The Lancet Global Health 9 (1), e81-e90, 2021 | 75 | 2021 |
| NOD2 and CCDC122-LACC1 genes are associated with leprosy susceptibility in Brazilians C Sales-Marques, H Salomão, VM Fava, LE Alvarado-Arnez, EP Amaral, ... Human genetics 133, 1525-1532, 2014 | 74 | 2014 |
| Primary neural leprosy: systematic review JA Garbino, W Marques Jr, JA Barreto, CO Heise, MMJ Rodrigues, ... Arquivos de neuro-psiquiatria 71, 397-404, 2013 | 60 | 2013 |
| Ocular leprosy A Grzybowski, M Nita, M Virmond Clinics in Dermatology 33 (1), 79-89, 2015 | 58 | 2015 |
| Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases MMA Stefani, C Avanzi, S Bührer-Sékula, A Benjak, C Loiseau, P Singh, ... PLoS neglected tropical diseases 11 (6), e0005598, 2017 | 53 | 2017 |
| Leprosy in the Bible A Grzybowski, M Nita Clinics in dermatology 34 (1), 3-7, 2016 | 52 | 2016 |
| An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++ LF Mieras, AT Taal, WH Van Brakel, E Cambau, PR Saunderson, ... BMC infectious diseases 18, 1-8, 2018 | 51 | 2018 |
| Cirurgia reparadora e reabilitação em hanseníase F Duerksen, M Virmond Bauru: ALM Internacional. Centro de Estudos Dr. Reinaldo Quagliato …, 1997 | 48 | 1997 |
| Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon PS Rosa, HRS D’Espindula, ACL Melo, ANB Fontes, AJ Finardi, ... Clinical infectious diseases 70 (10), 2054-2061, 2020 | 45 | 2020 |
| Neuropathic pain in leprosy I Raicher, PRNAG Stump, R Baccarelli, LHSC Marciano, S Ura, ... Clinics in Dermatology 34 (1), 59-65, 2016 | 40 | 2016 |
| Hanseníase: episódios reacionais NT Foss, CS Souza, IM Goulart, HS Gonçalves, M Virmond | 39 | 2003 |
| Time to define leprosy elimination as zero leprosy transmission? CS Smith, A Aerts, E Kita, M Virmond The Lancet Infectious Diseases 16 (4), 398-399, 2016 | 37 | 2016 |
| Criação de banco de dados para sustentação da pós-eliminação em hanseníase VDA Paschoal, SMT Nardi, MRCO Cury, C Lombardi, MCL Virmond, ... Ciência & Saúde Coletiva 16 (suppl 1), 1201-1210, 2011 | 37 | 2011 |
| A randomized clinical trial of oral steroids for ulnar neuropathy in type 1 and type 2 leprosy reactions JA Garbino, MCL Virmond, S Ura, MH Salgado, B Naafs Arquivos de neuro-psiquiatria 66, 861-867, 2008 | 36 | 2008 |
| Hanseníase: diagnóstico e tratamento da neuropatia JA Garbino, JA Nery, M Virmond, PR Stump, R Baccarelli, ... | 36 | 2003 |
